1.6
View the full transcript and gain access to JoVE Core videos
Q1: What is the difference between dysplasia and metaplasia?
Dysplasia is abnormal changes in cell size, shape, and organization reflecting preneoplastic changes with cancer potential, while metaplasia is reversible replacement of one mature cell type with another better suited to environmental stress. Dysplasia is not a true adaptive response, whereas metaplasia represents an adaptive mechanism involving stem cell reprogramming in response to growth factors and cytokines.
Q2: Why is dysplasia considered a preneoplastic change?
Dysplasia exhibits pleomorphism, nuclear abnormalities, and increased mitotic activity that distinguish it from normal tissue. When confined above the basement membrane, dysplasia may be reversible if the underlying cause is removed. However, once cells breach the basement membrane, they become invasive carcinoma, making dysplasia a critical precancerous stage requiring monitoring and intervention.
Q3: How does metaplasia occur in response to chronic injury?
Metaplasia arises from reprogramming of stem cells or colonization by differentiated cells from nearby sites, which follow different maturation paths in response to growth factors and cytokines. In smokers, chronic smoke exposure replaces ciliated columnar epithelium with stratified squamous epithelium. While initially protective, persistent injury can lead to genetic changes progressing to dysplasia and carcinoma.
Q4: What are the consequences of respiratory metaplasia in smokers?
In long-term smokers, chronic smoke exposure replaces normal ciliated columnar epithelium in the trachea and bronchi with stratified squamous epithelium. These metaplastic cells lack cilia and mucus secretion, impairing airway protection and mucociliary clearance. This adaptation, though initially protective against smoke irritation, compromises normal respiratory defense mechanisms.
Q5: How does Barrett esophagus develop and what is its significance?
Barrett esophagus occurs when chronic gastroesophageal reflux prompts replacement of squamous epithelium in the distal esophagus with intestinal-type columnar cells. Although these metaplastic cells are more resistant to acid, this change increases the risk for esophageal adenocarcinoma. It exemplifies how metaplasia, while initially protective, can progress to malignancy with persistent injury.
Q6: Can dysplasia be reversed if the causative stimulus is removed?
Dysplasia confined to part of the epithelium above the basement membrane may be reversible if the underlying cause is removed. However, once dysplasia breaches the basement membrane and becomes invasive carcinoma, reversal is not possible. Early detection and removal of the causative stimulus are critical for preventing progression to irreversible invasive disease.
Q7: What tissues are most commonly affected by dysplasia and metaplasia?
Dysplasia and metaplasia commonly affect epithelial tissues including the cervix, gastrointestinal tract, respiratory mucosa, endometrium, and esophagus. These tissues are particularly vulnerable because they are frequently exposed to environmental irritants, chronic inflammation, and cellular adaptation signals. Understanding which epithelial tissues are at risk helps guide clinical surveillance and intervention strategies.